FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921130376> ?p ?o ?g. }

• W2921130376 endingPage "685.e4" @default.
• W2921130376 startingPage "678" @default.
• W2921130376 abstract "Background Most important markers in chronic lymphocytic leukemia (CLL) are TP53 abnormalities, including mutations and deletions, and the mutational status of immunoglobulin heavy chain (IGHV) genes. However, some recent publications suggest that the IGHV mutational load could have a prognostic effect on CLL patients. Patients and Methods We performed a single-center retrospective study on 459 patients with productive rearrangement of the B-cell receptor to evaluate the prognostic and predictive role of IGHV mutational status and burden within the germline sequence. In particular we focused on FCR (fludarabine with cyclophosphamide, and rituximab)- (64 naive and 30 relapsed) and BR (bendamustine with rituximab)-treated patients (17 naive and 61 relapsed). A cutoff value of 2% of difference within the IGHV germline was used to define the IGHV mutational status. Results We reported that unmutated IGHV (U-IGHV) patients were characterized by a significant shorter progression-free survival (PFS) and overall survival (P < .0001) compared with mutated IGHV (M-IGHV) patients. Moreover, treatment-naive M-IGHV patients experienced a long-term disease control after FCR or BR, with PFS reaching a plateau regardless of mutational load. In our series the extent of IGHV gene mutation did not provide further relevant prognostic data over the mutational status. Relapsed patients showed dismal outcome with chemoimmunotherapy regardless of IGHV status or load. Conclusion Our data, together with from those from the literature, confirmed the cutoff value of 2% to define the mutational status of IGHV gene and suggest that FCR/BR are good first-line treatment strategies for M-IGHV patients, whereas U-IGHV patients should be managed with B-cell receptor and/or B-cell lymphoma 2 (BCL2) inhibitors." @default.
• W2921130376 created "2019-03-22" @default.
• W2921130376 creator A5003316216 @default.
• W2921130376 creator A5009372491 @default.
• W2921130376 creator A5013236194 @default.
• W2921130376 creator A5017931505 @default.
• W2921130376 creator A5021204507 @default.
• W2921130376 creator A5031832443 @default.
• W2921130376 creator A5042091314 @default.
• W2921130376 creator A5042259231 @default.
• W2921130376 creator A5042867938 @default.
• W2921130376 creator A5045920287 @default.
• W2921130376 creator A5051849628 @default.
• W2921130376 creator A5058373325 @default.
• W2921130376 creator A5081541878 @default.
• W2921130376 creator A5087722204 @default.
• W2921130376 creator A5091203975 @default.
• W2921130376 date "2019-10-01" @default.
• W2921130376 modified "2023-10-17" @default.
• W2921130376 title "Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments" @default.
• W2921130376 cites W1196637763 @default.
• W2921130376 cites W1243376384 @default.
• W2921130376 cites W1429374962 @default.
• W2921130376 cites W1565211228 @default.
• W2921130376 cites W1876001658 @default.
• W2921130376 cites W1966122750 @default.
• W2921130376 cites W1980260104 @default.
• W2921130376 cites W2052521024 @default.
• W2921130376 cites W2082312121 @default.
• W2921130376 cites W2084952484 @default.
• W2921130376 cites W2140606816 @default.
• W2921130376 cites W2142099365 @default.
• W2921130376 cites W2144617723 @default.
• W2921130376 cites W2148495628 @default.
• W2921130376 cites W2149515595 @default.
• W2921130376 cites W2151177887 @default.
• W2921130376 cites W2163348695 @default.
• W2921130376 cites W2208017095 @default.
• W2921130376 cites W2295348655 @default.
• W2921130376 cites W2318933236 @default.
• W2921130376 cites W2337485820 @default.
• W2921130376 cites W2343855217 @default.
• W2921130376 cites W2396328865 @default.
• W2921130376 cites W2430283214 @default.
• W2921130376 cites W2522303258 @default.
• W2921130376 cites W2549439275 @default.
• W2921130376 cites W2563529755 @default.
• W2921130376 cites W2581800404 @default.
• W2921130376 cites W2624598927 @default.
• W2921130376 cites W2769052922 @default.
• W2921130376 cites W2790775250 @default.
• W2921130376 cites W2802589270 @default.
• W2921130376 cites W2818760726 @default.
• W2921130376 cites W2900467419 @default.
• W2921130376 cites W2902484351 @default.
• W2921130376 cites W4235474157 @default.
• W2921130376 doi "https://doi.org/10.1016/j.clml.2019.03.002" @default.
• W2921130376 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31371221" @default.
• W2921130376 hasPublicationYear "2019" @default.
• W2921130376 type Work @default.
• W2921130376 sameAs 2921130376 @default.
• W2921130376 citedByCount "23" @default.
• W2921130376 countsByYear W29211303762019 @default.
• W2921130376 countsByYear W29211303762020 @default.
• W2921130376 countsByYear W29211303762021 @default.
• W2921130376 countsByYear W29211303762022 @default.
• W2921130376 countsByYear W29211303762023 @default.
• W2921130376 crossrefType "journal-article" @default.
• W2921130376 hasAuthorship W2921130376A5003316216 @default.
• W2921130376 hasAuthorship W2921130376A5009372491 @default.
• W2921130376 hasAuthorship W2921130376A5013236194 @default.
• W2921130376 hasAuthorship W2921130376A5017931505 @default.
• W2921130376 hasAuthorship W2921130376A5021204507 @default.
• W2921130376 hasAuthorship W2921130376A5031832443 @default.
• W2921130376 hasAuthorship W2921130376A5042091314 @default.
• W2921130376 hasAuthorship W2921130376A5042259231 @default.
• W2921130376 hasAuthorship W2921130376A5042867938 @default.
• W2921130376 hasAuthorship W2921130376A5045920287 @default.
• W2921130376 hasAuthorship W2921130376A5051849628 @default.
• W2921130376 hasAuthorship W2921130376A5058373325 @default.
• W2921130376 hasAuthorship W2921130376A5081541878 @default.
• W2921130376 hasAuthorship W2921130376A5087722204 @default.
• W2921130376 hasAuthorship W2921130376A5091203975 @default.
• W2921130376 hasConcept C104317684 @default.
• W2921130376 hasConcept C109825262 @default.
• W2921130376 hasConcept C126322002 @default.
• W2921130376 hasConcept C143998085 @default.
• W2921130376 hasConcept C203014093 @default.
• W2921130376 hasConcept C2776694085 @default.
• W2921130376 hasConcept C2776755627 @default.
• W2921130376 hasConcept C2777609679 @default.
• W2921130376 hasConcept C2777938653 @default.
• W2921130376 hasConcept C2778461978 @default.
• W2921130376 hasConcept C2779263901 @default.
• W2921130376 hasConcept C2779338263 @default.
• W2921130376 hasConcept C2780653079 @default.
• W2921130376 hasConcept C54355233 @default.
• W2921130376 hasConcept C71924100 @default.

• next